生命科学资讯

Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump

Windward gets bispecific from Qyuns in its second China deal of the year

Shionogi will pay $2.5B to acquire one of the only approved ALS drugs

Trump to test ‘most favored nation’ pricing for Medicare; Shionogi pays $2.5B for ALS drug

The Zacks Analyst Blog Highlights Walmart, Wells Fargo, Thermo Fisher Scientific, Seneca Foods and NetSol Technologies - Yahoo Finance

The Zacks Analyst Blog Highlights Walmart, Wells Fargo, Thermo Fisher Scientific, Seneca Foods and NetSol Technologies - Yahoo Finance Singapore

FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM

Agilent Opens India Refurbishment Center for Sustainable Science - Environment+Energy Leader

Biggest gainers and losers for Dec. 15-19, 2025

The Zacks Analyst Blog Highlights Walmart, Wells Fargo, Thermo Fisher Scientific, Seneca Foods and NetSol Technologies - Zacks Investment Research

Ipsen gains access to ADC from Shanghai biotech Simcere Zaiming

10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus

10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus

Radiopharmaceutical specialist Aktis seeks an IPO

Illumina (NASDAQ:ILMN) Price Target Raised to $130.00 - MarketBeat

10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat

Boehringer taps Rectify to create pills for chronic kidney disease

Biopharma CEO optimism is wavering in the U.S.

Laekna Pharmaceutical divulges new PI3Kα inhibitors

Aché Laboratórios Farmacêuticos describes new SGLT-1, SGLT-2 and DPP4 inhibitors